期刊文献+

重组腺病毒介导MRP反义RNA逆转人肝癌细胞多药耐药表型的体外实验研究 被引量:8

Reversal of the multidrug resistance in human hepatocellular carcinoma cells by recombinant adenoviral delivery of the MRP antisense RNA in vitro
原文传递
导出
摘要 目的探讨重组腺病毒介导的多药耐药相关蛋白(MRP)反义RNA对阿霉素诱导的人肝癌耐药细胞株SMMC-7721/ADM多药耐药表型的体外逆转作用。方法应用自行构建的携带反义MRP的重组腺病毒(Ad-Asm rp),在体外转染人肝癌耐药细胞,测定转染后细胞对阿霉素(ADM)及柔红霉素(DNR)的半数致死量(IC50)并计算耐药倍数(RF值);在转染后不同时间点用流式细胞仪动态测定细胞对DNR摄取的变化及细胞膜表面P190表达、并用RT-PCR反映细胞MRP之mRNA水平的变化。结果携带MRP反义RNA的重组腺病毒转染后的人肝癌耐药细胞对ADM、DNR的IC50分别为0.487μg/m l、0.328μg/m l,RF值分别为97.4、109.3,RF值分别下降36.8和35.4。在转染后24 h,MRP mRNA水平开始下降并呈持续下降趋势(P<0.01),48 h后伴有P190蛋白表达的持续下降(P<0.01),二者趋势一致。转染后48 h,经流式细胞仪测得细胞内DNR浓度明显上升(P<0.01)。结论重组腺病毒介导的MRP反义RNA可有效封闭MRP基因表达,在体外实验中能增加人肝癌耐药细胞株对化疗药物的敏感性,对肝癌耐药细胞的MDR表型有较好的逆转作用。 Objective To investigate the effects of multidrug resistance-associated protein (MRP) antisense RNA mediated by recombinant adenoviruses on reversal of the multidrug resistance (MDR) in human drug-resistant hepatocellular carcinoma (HCC) cells. Methods HCC cells of the line SMMC-7721/ ADM were cultured in a 96-well-plate and transfected with recombinant adenovirus Ad-ASmrp containing antisense MRP. Another SMMC-7721/ADM cells were transfected with Ad-GFP or added with PBS were used as controls. The cells were collected from 3 wells everyday for 7 days to observe the absorbance so as to draw a growth curve. SMMC-7721/ADM cells were transfected with Ad-ASmrp and Ad-GFP, added with adriamycin (ADM) or daunorubicin (DNR) , and then cultured for 48 hours. The chemosensitivity of the cells to ADM and DNR was determined by MTT assay. The levels of MRP mRNA and its product P190 were measured by RT-PCR and flow cytometry (FCM) 24, 48, 72, 96, and 120 hours after respectively. The accumulation of DNR in these cells was analyzed by FCM simultaneously. Results The IC50 values of the cells transfected with Ad-Asmrp to ADM and DNR were 0.487 μg/ml and 0.328μ g/ml , and the factors of resistance (RF) decreased by 36.8 and 35.4 respectively (both P 〈 0.05 ). Continuous decrease in levels of MRP mRNA and P190 was observed 24 h and 48h after transfection respectively (both P 〈 0.01 ). The intracellular DNR accumulation was increased simultaneously in the Ad-Asmrp transfected cells (P 〈 0.01 ). Conclusions MRP antisense RNA mediated by recombinant adenovirus increases chemosensitivity and partially reverses the MDR in HCC cells in vitro by inhibiting the expression of MRP gene.
出处 《中华医学杂志》 CAS CSCD 北大核心 2005年第38期2719-2723,共5页 National Medical Journal of China
基金 国家自然科学基金资助项目(30170925)
关键词 抗药性 多药 RNA 反义 肝肿瘤 重组腺病毒 MRP基因表达 多药耐药相关蛋白 重组腺病毒介导 人肝癌细胞 体外实验研究 反义RNA Drug resistance, multiple RNA, antisense Liver neoplasms Recombinant adenovirus
  • 相关文献

参考文献9

  • 1戴越盟,林琦远,严律南,林萍,智星,雷松,屈艺.多药耐药相关蛋白在阿霉素诱导人肝癌细胞SMMC-7721耐药性产生中的作用及机理[J].中国普外基础与临床杂志,2001,8(1):8-11. 被引量:11
  • 2杨家印,罗华友,林琦远,严律南,林萍,雷松,黄代新,赵永恒.反义寡核苷酸降低细胞株SMMC-7721/ADM之MRP基因表达的研究[J].中国普外基础与临床杂志,2001,8(3):141-144. 被引量:7
  • 3陈琳,苟兴华,严律南,韩蕾,李德华,赵永恒,胡海洋.携带反义多药耐药相关蛋白的重组腺病毒载体的构建[J].四川大学学报(医学版),2003,34(1):131-134. 被引量:4
  • 4Cole SPC, Bhardwa JG, Gerlach JH, et al. Overexpression of transporter gene in a mulfidrug-resistant human lung cancer cell line.Science, 1992, 258 : 1650-1654.
  • 5Bradshaw DM, Arceci BJ. Clinical relevance of transmembrane drug efflux as a mechanism of multidrug resistance. J Clin Oncol, 1998,16 : 3674 -3690.
  • 6Breunlnger LM, Paul S, Gaughan K, et al. Expression of multidrug resistance-associated protein in NIH/3T3 cells coders muhidrug resistance associated with increased drug etllux and altered intracellular drug distribution. Cancer Res, 1995, 55:5342-5347.
  • 7Hipfner DR, Deeley RG, Coloe SP. Structural, mechanistic and clinical aspects of MRPI. Biochim Biophys Acta, 1999, 1461:359-376.
  • 8Sczakiel G. The design of antisense RNA. Antisense Nucleic Acid Drug Dev, 1997, 7:439-444.
  • 9Richert ND, Aldwin L, Nitesci D, et al. Stability and covalent modification of P-glycoprotein in multidrug resistance KB cells.Biochemistry, 1988, 27:760.

二级参考文献18

  • 1刘炳仁,杨纯正,栾凤君,熊冬生,刘瑞林,卞寿庚,薛艳萍,郝玉书.用逆转录-多聚酶链反应检测白血病患者多药耐药基因的表达[J].中华血液学杂志,1995,16(2):65-68. 被引量:27
  • 2[1]Cole SPC, Bhardwa JG, Gerlach.JH, et al. Overexpression of transporter gene in a multidrug-resistant human lung cancer cell line. Science, 1992; 258(5088): 1650
  • 3[2]Hipfner DR, Deeley RG, Coloe SP. Structural, mechanistic and clinical aspects of MRP1. Biochim Biophys Acta, 1999;1461(2): 359
  • 4[3]Roelofsen H, Vos TA, Schippers IJ, et al. Increased levels of the multidrug resistance protein in lateral membranes of proliferating hepatocyte derived cells. Gastroenterology, 1997; 112(2): 511
  • 5[5]Carter G, Lemoine NR. Antisense technology for cancer therapy: does it make sense?. Br J Cancer, 1993; 67(5): 869
  • 6[6]He TC, Zhou S, Da Costa LT, et al. A simplified system for generating recombinant adenovirus. Proc Natl Acad Sci USA, 1998; 95(5): 2509
  • 7[7]Inoue H, Nojima H, Okayama H. High efficiency transformation of Escherichia coli with plasmids. Gene, 1990; 96(1): 23
  • 8[8]Itsubo M, Ishikawa T, Toda G, et al. Immunohistochemic study of expression and cellular localization of the multidrug resistance gene product p-glycoprotein in primary liver carcinoma. Cancer, 1994; 73(2): 298
  • 9[9]Lai EC, Choi TK, Cheng CH, et al. Doxorubicin for unresectable hepatocellular carcinoma, A prospective study on the addition of verapami. Cancer, 1990; 66(8): 1685
  • 10[10]Bradshaw DM, Arceci RJ. Clinical relevance of transmembrane drug efflux as a mechanism of multidrug resistance. J Clin Oncol, 1998; 16(11): 3674

共引文献14

同被引文献86

引证文献8

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部